TNGX vs TWLO · $5.36B cap vs P/E 1087, rev $2.91B
Tango Therapeutics Inc (TNGX) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
TNGX currently screens at market cap $5.36B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the TNGX and TWLO stock pages for the full models.
Not investment advice.